MED17

PF3D7_0520200 (MED17) is a subunit of the Plasmodium falciparum Mediator complex, the coactivator module associated with RNA polymerase II transcription (PMID:35557691). It was physically identified as an interaction partner of the conserved Mediator subunit PfMed31 by reciprocal coimmunoprecipitation and mass spectrometry, establishing its membership in the P. falciparum Mediator complex, with the head-module MED17 implicated in bridging the head and middle modules via a Med17–Med21 interaction conserved from yeast (PMID:35557691). Beyond its complex membership, no direct enzymatic activity, structure, or dedicated functional characterization of MED17 itself has been established in the available corpus; its only additional appearance is as one member of the PfSET10 nuclear interaction network during blood-stage development (PMID:39445823).

1. 2022 Medium

   Whether P. falciparum encodes a functional Mediator complex and which subunits associate was unresolved; identifying MED17 as a PfMed31 partner established that PF3D7_0520200 is a bona fide Mediator subunit rather than a merely annotated ortholog.

   Evidence Reciprocal coimmunoprecipitation of PfMed31 followed by mass spectrometry in P. falciparum

   PMID:35557691

   Open questions at the time

   • Single lab, single method; no reciprocal Co-IP starting from MED17 itself
   • The proposed Med17-Med21 head-to-middle bridging role is inferred from yeast conservation, not directly demonstrated in P. falciparum
   • No functional consequence of MED17 loss on transcription was tested
2. 2024 Low

   Whether MED17 participates in chromatin-associated regulatory networks beyond core Mediator was unknown; proximity labeling placed it in the PfSET10 nuclear network during intraerythrocytic development.

   Evidence TurboID proximity labeling coupled with mass spectrometry in P. falciparum blood stages

   PMID:39445823

   Open questions at the time

   • Proximity labeling reflects spatial neighborhood, not direct interaction; MED17 is one of many listed interactors with no MED17-specific follow-up
   • No evidence that MED17 is functionally required for PfSET10 activity or vice versa
   • Stage- and locus-specificity of any MED17 role remains uncharacterized

• The direct molecular function of MED17, its structural role within the Mediator complex, and any phenotype from its perturbation in P. falciparum remain unestablished.
• No genetic knockdown/knockout of MED17 to define its contribution to RNA Pol II transcription
• No structural or biochemical validation of the head-to-middle module bridging role in P. falciparum
• No target genes or transcriptional programs assigned to MED17